These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38336791)

  • 1. Detection of gene mutation in the prognosis of a patient with arrhythmogenic right ventricular cardiomyopathy: a case report.
    Phan DP; Tran TV; Le VK; Nguyen TV
    J Med Case Rep; 2024 Feb; 18(1):49. PubMed ID: 38336791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
    Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
    Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
    Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.
    Blusztein DI; Zentner D; Thompson T; Jayadeva P; Liang D; Wang R; Winship I; James PA; Trainer AH; Kalman JM; Vohra J
    Heart Lung Circ; 2019 Jul; 28(7):1034-1041. PubMed ID: 30126789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
    Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
    JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.
    Azaouagh A; Churzidse S; Konorza T; Erbel R
    Clin Res Cardiol; 2011 May; 100(5):383-94. PubMed ID: 21360243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Bosman LP; Te Riele ASJM
    Heart; 2022 Jan; 108(2):90-97. PubMed ID: 33990412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Gasperetti A; James CA; Carrick RT; Protonotarios A; Te Riele ASJM; Cadrin-Tourigny J; Compagnucci P; Duru F; van Tintelen P; Elliot PM; Calkins H
    Europace; 2023 Nov; 25(11):. PubMed ID: 37935403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy.
    Zinkovsky D; Sood MR
    J Cardiovasc Electrophysiol; 2023 Oct; 34(10):2112-2121. PubMed ID: 37717241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
    Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Silvano M; Corrado D; Köbe J; Mönnig G; Basso C; Thiene G; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2013 Dec; 24(4):202-8. PubMed ID: 24113835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
    Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
    Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
    Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation.
    Lin Y; Huang J; He S; Feng R; Zhong Z; Liu Y; Ye W; Li X; Liao H; Fei H; Rao F; Shan Z; Deng C; Zhan X; Xue Y; Liu H; Zhang B; Wang K; Zhang Q; Wu S; Lin X
    BMC Med Genet; 2018 Aug; 19(1):148. PubMed ID: 30129429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of arrhythmogenic right ventricular cardiomyopathy.
    Silvano M; Mastella G; Zorzi A; Migliore F; Pilichou K; Bauce B; Rigato I; Perazzolo Marra M; Iliceto S; Thiene G; Basso C; Corrado D
    Minerva Med; 2016 Aug; 107(4):194-216. PubMed ID: 27186923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.